Prostate cancer decisions — 2023

The Board has remanded the Veteran's claims for service connection for prostate cancer, right upper extremity peripheral neuropathy, left upper extremity peripheral neuropathy, right lower extremity peripheral neuropathy, and left lower extremity peripheral neuropathy due to exposure to herbicide agents. The AOJ is directed to undertake additional development including verifying the Veteran's reported exposure to herbicide agents in the Korean DMZ.

The Board has granted service connection for the Veteran's prostate cancer and bone cancer, with prostate cancer being granted on a direct basis due to in-service exposure to ionizing radiation. Bone cancer is granted as secondary to the now service-connected prostate cancer.

The Board denied the Veteran's claim for service connection for prostate cancer, including due to herbicide agent exposure, finding no evidence of in-service exposure and insufficient medical evidence linking the condition to his military service.

The Board has granted service connection for prostate cancer and multiple myeloma, finding that the Veteran was exposed to herbicide agents during his service in Korea. These conditions are presumed related due to his exposure.

The Veteran's claim of service connection for prostate cancer was reopened due to new evidence submitted since the last denial. The Board found that while the Veteran served in Southwest Asia during the Gulf War, there is no evidence of herbicide exposure and the prostate cancer is not related to his service.

The Board has remanded the claims for service connection for prostate cancer and diabetes mellitus, type II due to exposure to herbicide agents (Agent Orange) as the VA failed to verify the Veteran's claimed exposure at Fort McClellan. The case will be referred for a formal finding that sufficient information required to verify herbicide agent exposure does not exist.

The Veteran's claims for initial compensable disability ratings for residuals of prostate cancer and erectile dysfunction have been denied. The evidence does not support the assignment of a higher rating for either condition.

The Board has remanded the claims for sleep apnea, prostate cancer, and respiratory disability due to lack of substantial compliance with previous remand requests.

The Board has granted service connection for bilateral hearing loss disability. The claims of service connection for prostate cancer, impotence, and acquired psychiatric disability (secondary to prostate cancer) are remanded due to the need for additional medical opinions.

The Veteran's balanitis is granted as secondary to his service-connected prostate cancer status post radical prostatectomy. The rating for bilateral hearing loss remains at 10 percent, but the issue of a higher rating is remanded due to insufficient evidence.

The Veteran's prostate cancer and erectile dysfunction are granted service connection, with prostate cancer being presumed due to herbicide agent exposure in Thailand. Erectile dysfunction is found to be secondary to the prostate cancer.

The Veteran's cause of death is granted due to service connection for prostate cancer, which is presumed due to herbicide agent exposure during his service at Nakhon Phanom RTAFB in Thailand. The PACT Act expanded the scope of presumed herbicide agent exposure.

The Veteran's prostate cancer residuals, which did not result in local recurrence or metastasis after his 2014 prostatectomy, are rated at 60 percent since July 27, 2018.

The Board denied the Veteran's claim for service connection of prostate cancer, finding that there is no evidence to support a link between his current prostate cancer and his military service. The prostate cancer was found to be metastatic from a rectal cancer, which itself is not service-connected.

The Veteran's appeal for service connection and rating of various conditions has been denied. The Board found no evidence to support the claims for bilateral hearing loss, plantar fasciitis, posterior tibial tendon dysfunction, diabetes mellitus, prostate cancer, glaucoma, cataracts, or allergic rhinitis.

The Veteran's bilateral hearing loss is currently rated as noncompensable. The Board has remanded the cases for further development and opinion regarding service connection for diabetes mellitus, prostate cancer, and erectile dysfunction due to exposure at Camp Lejeune.

The Board has denied service connection for the Veteran's left ankle condition and remanded the cases of his bilateral kidney condition and prostate cancer due to conflicting medical opinions and need for additional development.

The Veteran's prostate cancer is granted as service connected due to presumed exposure to herbicide agents during his time at Fort Gordon.

The Board denied earlier effective dates for the awards of service connection for CAD, scars, prostate cancer, diabetes, and diabetic nephropathy. The effective date was assigned based on the date of claim or the date entitlement arose, whichever is later.

The Veteran's claim for service connection for prostate cancer was reopened and granted, with the condition having its onset in service.,Service connection for erectile dysfunction (ED) due to treatment of his service-connected prostate cancer was also granted.